山东药玻 (600529)

Shandong Pharmaceutical Glass Co., Ltd.

ASH

Tags

SSE 380 IndexBroker Heavy PositionsMedical DevicesPharmaceuticals and HealthcareSustainable GrowthHigh-Performing StocksMargin Trading and Securities LendingNon-Metallic Mineral Products

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 66361.41
  • Circulating A-Shares(W): 66361.41
  • Earnings Per Share(RMB): 0.8174
  • Net Assets Per Share(RMB): 12.2798
  • Operating Revenue(W RMB): 340051.69
  • Total Profit(W RMB): 64839.13
  • **Net Profit Attributable to Parent(W RMB) **: 54245.37
  • Net Profit Growth Rate(%): -24.70
  • Weighted Return on Equity(%): 6.6500
  • Operating Cash Flow Per Share(RMB): 0.7700
  • Undistributed Profit Per Share(RMB): 6.2080
  • Capital Reserve Per Share(RMB): 4.0492

2. Main Business

The main business covers:

  • Manufacturing and sales of various medicinal glass packaging products

3. Company Basic Information

  • Company Name: Shandong Pharmaceutical Glass Co., Ltd.
  • Listing Date: 2002-06-03
  • Industry: Non-metallic Mineral Products Industry
  • Address: Yiyuan County, Zibo City, Shandong Province
  • Website: https://www.pharmglass.com
  • Company Profile: The company's predecessor was Shandong Pharmaceutical Glass General Factory, established in 1970 and a national second-grade enterprise. In March 1993, approved by the Zibo Economic System Reform Commission, the original Shandong Pharmaceutical Glass General Factory acted as the sole sponsor and underwent a complete restructuring to establish the company through a private placement. The registered capital at the time of establishment was 22.8088 million yuan. Approved by the China Securities Regulatory Commission, the company successfully issued 32 million public shares on the Shanghai Stock Exchange on May 17, 2002, with an issue price of 12.18 yuan. The company completed the capital verification procedure on May 23, 2002, and the registered capital was changed to 82.407448 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shandong Luzhong Investment Co., Ltd. General Legal Person 12938.10 19.50
2 Huabao CSI Medical ETF Fund 1876.89 2.83
3 CSI 500 ETF Fund 965.34 1.45
4 National Social Security Fund 109 Portfolio Social Security Fund 740.85 1.12
5 CITIC Securities Co., Ltd. Broker 691.57 1.04
6 Hong Kong Securities Clearing Company Ltd. Northbound Capital 658.26 0.99
7 China Life Insurance Company Limited - Traditional - General Insurance Products - 005L-CT001 Shanghai General Legal Person 595.01 0.90
8 Yongying CSI Total Return Medical Equipment ETF Fund 409.36 0.62
9 Harvest CSI Vaccine and Biotechnology ETF Fund 33.99 0.05
10 China Universal CSI Total Return Medical Equipment ETF Fund 26.93 0.04

5. Concept Sectors

  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Heavily Held by Brokers
  • Heavily Held by Social Security Funds
  • Sustained Growth
  • SSE 380 Index

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information